Uterine rupture with the use of a low-dose vaginal PGE2 tablet--is it safe?
Ulmsten
U
U
D000282:Administration, Intravaginal; D015232:Dinoprostone / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000009:adverse effects* / Q000379:methods*; D011247:Pregnancy; D013607:Tablets; D014597:Uterine Rupture / Q000139:chemically induced*
D013607:Tablets; D015232:Dinoprostone